1. Home
  2. CIX vs MREO Comparison

CIX vs MREO Comparison

Compare CIX & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

HOLD

Current Price

$24.22

Market Cap

284.2M

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.65

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
MREO
Founded
1993
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.2M
324.6M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CIX
MREO
Price
$24.22
$0.65
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$3.90
AVG Volume (30 Days)
5.3K
36.8M
Earning Date
03-04-2026
11-10-2025
Dividend Yield
9.07%
N/A
EPS Growth
2.86
N/A
EPS
1.57
N/A
Revenue
$159,004,000.00
$500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$163.84
P/E Ratio
$15.47
N/A
Revenue Growth
5.52
N/A
52 Week Low
$17.89
$0.20
52 Week High
$32.30
$3.26

Technical Indicators

Market Signals
Indicator
CIX
MREO
Relative Strength Index (RSI) 56.50 35.75
Support Level $22.57 $0.51
Resistance Level $24.62 $0.78
Average True Range (ATR) 0.47 0.10
MACD 0.11 0.02
Stochastic Oscillator 59.81 77.67

Price Performance

Historical Comparison
CIX
MREO

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: